2011 Speakers Include:

Gary E. Lupinacci Assistant Branch Chief
Certified Cargo Screening Program, TSA/TSNM
Department of Homeland Security
Viq Pervaaz
Senior Vice President, Corporate Transactions and Transformation; Pharma Industry Initiative Leader
Aon Hewitt
Dr. Mary Foster
Chair, Packaging and Storage Expert Committee
US Pharmacopeia (USP)
Gary Hutchinson
Director of Corporate Transportation
Amgen
Chuck Forsaith
Corporate Director, Supply Chain Security
Purdue
Andrea Graf-Gruber
Manager, Cargo Business Process and Standards
International Air Transport Association (IATA)
Randy Desir
Manager, International Sourcing and Supplier Performance
Johnson & Johnson
Alan J. Davis
Supply Chain Temperature Control Leader
Johnson & Johnson
Martha Kliss
Manager, US Distribution and Import/Export
UCB Inc.
Geoffrey Glauser
Biomedical Advanced Research and Development Authority (BARDA)
U.S. Department of Health & Human Services (HHS)
Maryann Gribbin
Director Quality Assurance, Global Pharmaceutical Supply Group
Johnson & Johnson
Jim Lucie
Senior Manager, Material Control
AMAG Pharmaceuticals
John Kelly
Director Operations
Oxford Immunotec
Katy Ostertag
Clinical Supply Planner
Vertex Pharmaceuticals
Aruna Palnitkar
Manager, QA, External Manufacturing
sanofi-aventis, Mumbai, India
Bill Wyrovsky
Associate Director, Regional Logistics Clinical Supply Operations
Bristol Myers Squibb
Ian Holloway
Manager, Defective Medicines Report Centre
The Medicines and Healthcare products Regulatory Agency (MHRA)

Sarah Skuce
Compliance Specialist
Health Canada

Learn more about the Exhibition Hall schedule and how you can spend one-on-one time with the cold chain speakers.

Cold Chain Survey Results

View the Cold Chain Survey Results - creating a chain of custody and collaborative supply chain partnerships are the most important initiatives for cold chain professionals

Cold Chain Photo Gallery

» View complete photo gallery

Watch last years videos

Past attendees say it best…

"Very good speakers and subject matter and was filled with information rather than basic concepts" Logistics Project Manager, Bilcare Inc.

"Very knowledgeable speakers.Very relevant for distribution" –Director, Distribution Operations, Pfizer

"One of the best conferences I have attended" QA Associate Director, Johnson & Johnson

"Very informative. Enjoyed having time to meet with vendors" – Packaging Engineer, Abbott Vascular

Secure, Cost-Effective Logistics and Quality Assurance for the Full Product Lifecycle

The 9th Annual Cold Chain & Temperature Control Global Forum will examine the modern cold chain – including all temperature range products and their regulatory requirements – as well as evolving sectors such as Medical Devices & Diagnostics, Generics, APIs, Clinical and Biologics and cell therapies.

VIEW THE FULL COLD CHAIN & TEMPERATURE MANAGEMENT AGENDA HERE

Check out the Directors, Heads & VPs of Warehousing, Distribution, Packaging, Supply Chain and Quality who are confirmed to attend already

New for 2011:

Ensure product quality from bulk ingredients to finished product with focused tracks dedicated to Product Lifecycle and APIs, including case studies from Merck, AMAG Pharmaceuticals, Sartorius Stedim Biotech and U.S. Department of Health & Human Services
Share best practices and learn how clinical supply stakeholders can work together to ensure no lost time, patient or bio samples at the Bio Clinical & Lab Logistics Focus Day
Learn the importance of SOP’s and Quality Agreements, trends in distribution and take part in practical demonstrations of packaging solutions and temperature monitoring at the Training Days on Good Transportation Practices for Air, Road and Ocean for Temperature-Sensitive Healthcare Products

See what else is new on the cold chain agenda here

Learn more about the Exhibition Hall schedule and how you can spend one-on-one time with the cold chain speakers.

A truly Global Forum for temperature control life sciences professionals

"The global biopharmaceuticals market, in 2009, was $106 billion, which is forecasted to grow 11.2% by 2016. The US biopharmaceuticals market alone was $68 billion in 2009". This growth of novel biological therapies such as monoclonal antibodies, cell therapies, cytokines and new vaccines, is setting the scene for tomorrow's cold chain, demanding specialty handling and distribution - 'do not shake', maintain x% humidity.

2011 is truly a Global Forum and will reflect these changes in the global market and bring hard-hitting new information, peer-to-peer experiences on overcoming the most pressing issues facing temp control logistics and QA professionals today. Hear from these global cold chain experts:

Arminda O. Montero, Distribution QA Program Manager, Strategic Quality Initiatives, Global Pharmaceutical Operations, Abbott, Mexico